SNaPshot: Screening for Many Mutations at Once
Zosia Chustecka November 11, 2011 — Sending off a tumor sample for a broad screening of genetic aberrations, instead of just a single test, increases the chance of finding a therapy that the patient...
View ArticleClik here to view.
Rational Therapeutics: Intelligent selection of drug combinations
Dear Subscriber, November marks Lung and Pancreatic Cancer Awareness month. Both these diseases typically remain undetected until the cancer has spread. With comparatively low response rates to...
View ArticleNational Cancer Institute says cancer data at Louisiana Tumor Registry meets...
THE ASSOCIATED PRESS First Posted: November 19, 2011 – 4:01 am NEW ORLEANS — For the second year in a row, the National Cancer Institute has given the Louisiana Tumor Registry top marks for data...
View ArticleDecember 19, 2011 Monday – 11:50 am EST inShare 1 Text Size Smaller Normal...
December 19, 2011 Monday – 11:50 am EST By Adam Daley Georgetown researchers say they have just significantly changed biomedical research. Researchers know that normal cells don’t last long once...
View ArticleClik here to view.
Introducing ATCC Tumor Cell Panels: Powerful New Tools for Cancer Research
Tuesday, February 7, 2012 ATCC launches valuable and gentically-diverse tumor cell panels for drug discovery, pathway analysis and functional genomics Manassas, VA (PRWEB) February 07, 2012 Searching...
View ArticleNew Patent Promises to Accelerate Cancer Trials
Computer system IDs suitable patients, helps new drugs reach market faster TAMPA, Fla., Feb. 14, 2012 /PRNewswire/ – A new patent has been issued to Moffitt Cancer Center for a computerized system that...
View ArticleDeception at Duke: Fraud in cancer care?
February 12, 2012 7:03 PM Chemotherapy can be a tough road for people with cancer, often debilitating and even dangerous. Which is why five years ago, when Duke University announced that it had an...
View ArticleDNA Sequencing Lays Foundation for Personalized Cancer Treatment
ScienceDaily (Apr. 1, 2012) — Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient’s...
View ArticleCompany Profile for Precision Therapeutics, Inc.
press release May 18, 2012, 10:40 a.m. EDT May 18, 2012 (BUSINESS WIRE) — Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer...
View ArticleTargeted Cancer Therapies Doomed to Fail?
By Michael Smith, North American Correspondent, MedPage Today Published: June 13, 2012 Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston and...
View Article
![Personal Investments • Re: 401k investments [which to choose?]](http://i.imgur.com/wA51OIw.png)
